BMC Neurol

1. LUQUE-LLANO M, Coronel MA, Sanguino-Caneva C, Gallo-Urina S, et al
   A dual manifestation of GAD-antibody spectrum disorder: a case of progressive encephalomyelitis with rigidity, myoclonus and autoimmune epilepsy with mesial temporal sclerosis.
   BMC Neurol. 2026 Mar 4. doi: 10.1186/s12883-025-04559.
   

   >> Share

   
   
2. TAN L, Huang Z, Zhu M, Sun Z, et al
   Clinical features and outcomes of anti-NMDAR autoimmune-related central nervous system involvement in patients with teratoma: a retrospective cohort study.
   BMC Neurol. 2026 Feb 27. doi: 10.1186/s12883-026-04717.
   

   >> Share

   
   
3. WANG X, Wang G, Xu J, Bai Y, et al
   Recurrent steroid-intolerant Hashimoto's encephalopathy responsive to single-dose neonatal Fc receptor antagonist: a case report and literature review.
   BMC Neurol. 2026 Feb 23. doi: 10.1186/s12883-026-04699.
   

   >> Share

   
   

   
   Curr Opin Immunol

4. JULIAN VELASCO-LANCHEROS O, Acosta-Ampudia Y, Monsalve DM, Ramirez-Santana C, et al
   Mpox virus immunology: exploring links to autoimmune diseases.
   Curr Opin Immunol. 2026;99:102744.
   

   >> Share

   
   

   
   Diabetes

5. BONFIELD G, Russ-Silsby J, Ramchand S, Luckett AM, et al
   Biallelic Pathogenic Variants in IL2RA Cause Neonatal-Onset Monogenic Autoimmune Diabetes.
   Diabetes. 2026 Feb 27:db250885. doi: 10.2337/db25-0885.
   

   >> Share

   
   

   
   Diabetes Res Clin Pract

6. PASSANISI S, Bombaci B, Longo A, Alibrandi A, et al
   The psychological impact of time in tight range in adolescents with type 1 diabetes: insights from real-life clinical practice.
   Diabetes Res Clin Pract. 2026;233:113160.
   

   >> Share

   
   
7. BALAKUMAR P, Khan NA, Easwaran V, Orayj KM, et al
   The impact of GLP-1 and incretin-based therapies on counterregulatory responses to hypoglycemia in diabetes mellitus: mechanisms and clinical implications.
   Diabetes Res Clin Pract. 2026;233:113155.
   

   >> Share

   
   
8. KWOK R, Kishore K, Zafari T, Koye DN, et al
   RenoTrue: A diabetes-specific machine learning model to estimate glomerular filtration rate for people with diabetes.
   Diabetes Res Clin Pract. 2026;233:113137.
   

   >> Share

   
   
9. GEORELI E, Sotiriou G, Chainoglou A, Galli-Tsinopoulou A, et al
   Longitudinal study of arterial stiffness in pediatric patients with Type 1 Diabetes Mellitus (T1DM). Correlations with glycemic metrics derived from Continuous Glucose Monitoring (CGM) devices.
   Diabetes Res Clin Pract. 2026;233:113132.
   

   >> Share

   
   
10. DI MOLFETTA S, Boscari F, Rossi A, Girelli A, et al
    Insights for personalized choice of a hybrid closed-loop system: an expert opinion.
    Diabetes Res Clin Pract. 2026;233:113120.
    

    >> Share

    
    
11. DEEB A, Al Saffar H, Yaqoob N, Scaramuzza AE, et al
    Diabetes technology use in the Middle East and Southeast Asia: penetrance, challenges, and unmet needs.
    Diabetes Res Clin Pract. 2026;233:113117.
    

    >> Share

    
    

    
    Intern Med

12. KURITA Y, Kubota K, Yoshimi R, Fujita Y, et al
    Effectiveness and Safety of Immunosuppressive Therapy in Recurrent Autoimmune Pancreatitis.
    Intern Med. 2026 Mar 3. doi: 10.2169/internalmedicine.6646.
    

    >> Share

    
    
13. OSHIMA S, Shimada M, Ikeda H, Mochizuki S, et al
    Atypical Presentation of Intravascular Large B-cell Lymphoma After Treatment for Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
    Intern Med. 2026;65:708-714.
    

    >> Share

    
    
14. UJITA W, Kamisawa T, Chiba K, Tabata H, et al
    Diffusion-weighted Whole-body Imaging with Background Body Signal Suppression Enables Simultaneous Whole-body Assessments of IgG4-related Diseases.
    Intern Med. 2026;65:632-639.
    

    >> Share

    
    

    
    J Autoimmun

15. CHENG V, Sayre EC, Amiri N, Cragg JJ, et al
    Perinatal use of targeted synthetic DMARDs and maternal-neonatal outcomes in autoimmune disease: A population-based cohort study.
    J Autoimmun. 2026;159:103538.
    

    >> Share

    
    

    
    J Immunol

16. AMDARE N, Ali R, Manganaro A, Baker JC, et al
    Islet-derived T cells from both mice and humans recognize conserved insulin A-chain peptides presented by HLA-C*03:04.
    J Immunol. 2026;215:vkaf381.
    

    >> Share

    
    

    
    Kidney Int

17. XIA X, Long C, Chen W, Yao X, et al
    METTL3-targeted intervention on nuclear factors RORA/RORgammat suppressing pathogenic T helper 17 cell differentiation and restores kidney damage in lupus nephritis.
    Kidney Int. 2026 Feb 19:S0085-2538(26)00133-X. doi: 10.1016/j.kint.2026.
    

    >> Share

    
    

    
    Lancet Neurol

18. MORGAN J
    Maria Pia Amato: focusing on cognitive health in multiple sclerosis.
    Lancet Neurol. 2026;25:230.
    

    >> Share

    
    

    
    Mult Scler

19. RIBONI-VERRI G, Gautam R, Chen B, Cunniffe NG, et al
    Myelination of the retinal nerve fibre layer: A case report.
    Mult Scler. 2026;32:347-350.
    

    >> Share

    
    
20. SHINODA K, Matsuyoshi A, Takeuchi H, Watanabe M, et al
    Diagnostic performance of central vein sign, paramagnetic rim lesion and cortical lesion in Asian patients with multiple sclerosis.
    Mult Scler. 2026 Feb 26:13524585261420650. doi: 10.1177/13524585261420650.
    

    >> Share

    
    
21. COHEN M, Mondot L, Ayrignac X, Vukusic S, et al
    Comparison of individuals with radiologically isolated syndrome, early multiple sclerosis patients, and healthy controls using a digital neurological examination.
    Mult Scler. 2026 Feb 22:13524585261418921. doi: 10.1177/13524585261418921.
    

    >> Share

    
    

    
    N Engl J Med

22. GOTTSCHLICH A, Bucklein V, El-Marouk K, Kaiser R, et al
    Blinatumomab in Combined Immune Thrombocytopenia and Antiphospholipid Syndrome.
    N Engl J Med. 2026;394:1030-1033.
    

    >> Share

    
    

    
    Neurol Clin Pract

23. COLLINS LC, Bagster MM, Tamlin L, Perez DL, et al
    Functional Neurologic Symptoms in Multiple Sclerosis: Estimated Prevalence and Associated Comorbidities.
    Neurol Clin Pract. 2026;16:e200569.
    

    >> Share

    
    

    
    Neurology

24. DE JONG DJ, Schoonheim MM
    The Role of Wearable Devices to Identify Patients at High Risk of Disease Progression in Multiple Sclerosis.
    Neurology. 2026;106:e214742.
    

    >> Share

    
    
25. FITZGERALD KC, Sanjayan M, Dewey BE, Guha Niyogi P, et al
    Association of Changes in Activity Patterns With Brain Atrophy and Disability Progression in People With Multiple Sclerosis.
    Neurology. 2026;106:e214678.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

26. CHIA PHJ, Toyonaga T, Tong J, Le H, et al
    SV2A PET reveals synaptic density loss in experimental autoimmune encephalomyelitis and in a pilot multiple sclerosis study.
    Proc Natl Acad Sci U S A. 2026;123:e2517709123.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share